Nutritional Status, Body Composition and Growth in Paediatric-Onset Ulcerative Colitis: A Systematic Review

Chen Sarbagili-Shabat1, Floor Timmer1, Konstantina Morogianni2

  • 1Division of Pediatric Gastroenterology and Nutrition, Department of Pediatrics, Amsterdam University Medical Centers, Emma Children's Hospital, 1105 AZ Amsterdam, The Netherlands.

Nutrients
|January 10, 2026
PubMed

Insights

Pediatric ulcerative colitis (UC) can lead to growth impairment and poor nutritional status in children and adolescents. More research is needed to fully understand UC

Area of Science:

  • Pediatric Gastroenterology
  • Inflammatory Bowel Disease Research
  • Nutritional Science in Pediatrics

Background:

  • Growth impairment and poor nutritional status are known complications of pediatric inflammatory bowel disease (IBD).
  • Specific data on ulcerative colitis (UC), a subset of IBD, are limited.
  • Understanding these issues in pediatric UC is crucial for effective management.

Purpose of the Study:

  • To systematically review and synthesize current knowledge on growth, nutritional status, and body composition in pediatric patients with UC.
  • To identify gaps in the existing literature regarding UC's impact on these parameters.
  • To inform future research directions.

Main Methods:

  • A systematic literature search was conducted up to August 2025.
  • Studies involving patients aged 5-22 years with confirmed UC were included.
  • Findings on growth, nutrition, and body composition were narratively synthesized.

Main Results:

  • Fifteen studies (1575 patients) met the criteria, with data often derived from broader IBD cohorts.
  • Growth failure affected 7-36% of patients, with weight deficits more prevalent than height deficits.
  • Undernutrition was observed in up to 25% of patients; body composition data were limited and inconsistent.

Conclusions:

  • Growth impairment and poor nutritional status are potential issues in pediatric UC.
  • Current data are limited by sample size and heterogeneity.
  • Larger, standardized studies specifically on UC, including body composition, are necessary.

Related Concept Videos

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
631
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
882
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
532
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
438
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
449
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.9K